Subscribe To
Moderna sues pfizer after saying it wouldn't enforce its patents for covid-19 vaccine technology
Moderna is suing competing vaccine maker Pfizer and its German partner BioNTech, alleging the pharmaceutical...
August 26, 2022, 9:05 am
Why aerie pharmaceuticals was soaring so high this week
You'd vault skyward, too, if a big-pocketed company were willing to spend a lot of coin on acquiring you....
August 26, 2022, 9:03 am
Forget bargain hunting: play 5 stocks with rising p/e
Bet on these top-ranked stocks with rising P/E to realize outsized gains. Tap Eastside Distilling (EAST), Adial ...
August 26, 2022, 9:02 am
Aptorum group limited to present at the h.c. wainwright annual global investment conference, september 13-16, 2022
NEW YORK & LONDON & PARIS--(BUSINESS WIRE)--Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) a clinical stage bio...
August 25, 2022, 8:31 pm
Rocket pharmaceuticals: updates to thesis, clinical momentum continues to accelerate
Shares have lost 15% year to date. Company wisely adopted a platform-agnostic approach to address first-in-class opportunities across the gene therapy...
August 25, 2022, 4:07 pm
Mind medicine ($mnmd) doses first patient in phase 2b trial to treat generalized anxiety disorder
Mind Medicine ($MNMD) a clinical stage biopharmaceutical company developing novel products to treat bra...
August 25, 2022, 3:58 pm
Clearside biomedical to present at the ophthalmology futures retina forum 2022
ALPHARETTA, Ga., Aug. 25, 2022 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceuti...
August 25, 2022, 7:05 am
Immuneering announces participation in september investor conferences
CAMBRIDGE, Mass., Aug. 25, 2022 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a biopharmaceutica...
August 25, 2022, 6:50 am
Positive abivertinib trial results push sorrento therapeutics (srne) 6.2% higher
Biopharmaceutical outfit Sorrento Therapeutics (US:SRNE) rallied +6.2% on Tuesday and extended gains by...
August 24, 2022, 9:12 pm
Blue water vaccines to present at the universal influenza vaccines 2022 conference in oxford, united kingdom
CINCINNATI, Aug. 24, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”) a bio...
August 24, 2022, 2:00 pm
Jazz pharmaceuticals: monopoly in the narcolepsy drug market
Jazz has a monopoly on the market for narcolepsy drugs. Narcolepsy patients require daily medication to keep functioning properly throughout the day. ...
August 24, 2022, 8:35 am
Inmed pharmaceuticals (inm) stock: 1-for-25 split announced
InMed pharmaceuticals (INM) announced it will be consolidating all of its issued and outstanding share ...
August 24, 2022, 7:05 am
Alcon to acquire aerie pharmaceuticals for $15.25 a share
Alcon agrees to acquire Aerie, the ophthalmic therapies company, for $15.25 a share....
August 23, 2022, 3:45 am
Adial clinical trial: a fluff or a win?
Onward Phase III Clinical Trial of Adial pharmaceutical's AD04, a treatment for Alcohol Abuse Disorder,...
August 22, 2022, 1:46 pm
Canntab therapeutics provides update on recent product delivery of its cannabinoid solutions to the nova scotia liquor corporation
Canntab Therapeutics Limited has provided an update on the recent product delivery of its unique pharmaceutica...
August 22, 2022, 7:48 am
Bellus health to present clinical data from phase 2b soothe trial of blu-5937 at the european respiratory society international congress 2022
LAVAL, Quebec--(BUSINESS WIRE)--BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) (“BELLUS Health” or the “Company”), a clinical-stage bio...
August 22, 2022, 7:00 am
Novartis: undervalued swiss pharma giant
Novartis is a global healthcare company with a research-driven focus on pharmaceuticals, both prescript...
August 21, 2022, 3:51 am
Pfizer is a solid high-yielding idea
Pfizer is a high-quality, high-yielding pharmaceutical company backed up by a robust drug portfolio. We...
August 11, 2022, 12:50 pm
Rvl pharmaceuticals plc (rvlp) reports q2 loss, tops revenue estimates
RVL pharmaceuticals PLC (RVLP) delivered earnings and revenue surprises of 20.83% and 0.57%, respective...
August 11, 2022, 12:03 pm
Rvl pharmaceuticals plc (rvlp) ceo brian markison on q2 2022 results - earnings call transcript
RVL pharmaceuticals plc (NASDAQ:RVLP ) Q2 2022 Earnings Conference Call August 11, 2022 8:30 AM ET Comp...
August 11, 2022, 12:01 pm